Seres Therapeutics, Inc. Announces Pricing of Initial Public Offering
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/1/2026
- Wall Street dips as higher yields, rising oil prices mark shaky start to SeptemberÂ
- Oil prices jump 4% as fresh US-Iran fighting stokes supply fears
- Two Saudi tankers struck in Strait of Hormuz Monday
- Fed’s Barr backs rate hike if inflation fails to cool, September odds hit 66%
- The Warsh pivot markets didn't expect
Seres Therapeutics (MCRB) IPO Opens Up 58%
June 26, 2015 11:53 AM EDTToday's IPO for Seres Therapeutics, Inc. (NASDAQ: MCRB) opened for trading at $28.50 after pricing 7,430,555 shares of common stock at a public offering price of $18.00 per share, above the expected $15-$17 range.
In addition, Seres Therapeutics granted the underwriters a 30-day option to... More
Seres Therapeutics (MCRB) IPO Prices at $18, Above Expected Range
June 26, 2015 8:52 AM EDTSeres Therapeutics, Inc. (NASDAQ: MCRB) announced the pricing of its initial public offering of 7,430,555 shares of common stock at a public offering price of $18.00 per share, above the expected $15-$17 range. The company's shares are expected to begin trading on The NASDAQ Global... More
